| STAT3 regulated ARF expression suppresses prostate cancer metastasis J Pencik, M Schlederer, W Gruber, C Unger, SM Walker, A Chalaris, ... Nature communications 6 (1), 7736, 2015 | 189 | 2015 |
| The role of activator protein-1 (AP-1) family members in CD30-positive lymphomas I Garces de los Fayos Alonso, HC Liang, SD Turner, S Lagger, O Merkel, ... Cancers 10 (4), 93, 2018 | 188* | 2018 |
| ALK in neuroblastoma: biological and therapeutic implications RM Trigg, SD Turner Cancers 10 (4), 113, 2018 | 182 | 2018 |
| PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas D Laimer, H Dolznig, K Kollmann, PW Vesely, M Schlederer, O Merkel, ... Nature medicine 18 (11), 1699-1704, 2012 | 151 | 2012 |
| Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK− anaplastic large-cell lymphoma O Merkel, F Hamacher, D Laimer, E Sifft, Z Trajanoski, M Scheideler, ... Proceedings of the National Academy of Sciences 107 (37), 16228-16233, 2010 | 131 | 2010 |
| Anaplastic large cell lymphoma in paediatric and young adult patients SD Turner, L Lamant, L Kenner, L Brugieres British Journal of Haematology 173 (4), 560-572, 2016 | 125 | 2016 |
| Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent L Johnson, JM O'donoghue, N McLean, P Turton, AA Khan, SD Turner, ... European Journal of Surgical Oncology (EJSO) 43 (8), 1393-1401, 2017 | 122 | 2017 |
| Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis S Harrison, R Lennon, J Holly, JPT Higgins, M Gardner, C Perks, T Gaunt, ... Cancer Causes & Control 28, 497-528, 2017 | 116 | 2017 |
| To waste or not to waste: questioning potential health risks of micro-and nanoplastics with a focus on their ingestion and potential carcinogenicity ES Gruber, V Stadlbauer, V Pichler, K Resch-Fauster, A Todorovic, ... Exposure and health 15 (1), 33-51, 2023 | 110 | 2023 |
| Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond N Prokoph, H Larose, MS Lim, GAA Burke, SD Turner Cancers 10 (4), 99, 2018 | 101 | 2018 |
| Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test P Rajaguru, LJ Fairbairn, J Ashby, MA Willington, S Turner, LA Woolford, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 444 (1 …, 1999 | 101 | 1999 |
| Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress TIM Malcolm, P Villarese, CJ Fairbairn, L Lamant, A Trinquand, CE Hook, ... Nature communications 7 (1), 10087, 2016 | 97 | 2016 |
| Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase SD Turner, R Tooze, K Maclennan, DR Alexander Oncogene 22 (49), 7750-7761, 2003 | 95 | 2003 |
| The AP-1-BATF and-BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N Schleussner, O Merkel, M Costanza, HC Liang, F Hummel, ... Leukemia 32 (9), 1994-2007, 2018 | 94 | 2018 |
| The transcriptional roles of ALK fusion proteins in tumorigenesis SP Ducray, K Natarajan, GD Garland, SD Turner, G Egger Cancers 11 (8), 1074, 2019 | 89 | 2019 |
| Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence X Ye, K Shokrollahi, WM Rozen, R Conyers, P Wright, L Kenner, ... Mutation Research/Reviews in Mutation Research 762, 123-132, 2014 | 89 | 2014 |
| The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms SD Turner, D Yeung, K Hadfield, SJ Cook, DR Alexander Cellular signalling 19 (4), 740-747, 2007 | 87 | 2007 |
| Insights into the pathogenesis of anaplastic large-cell lymphoma through genome-wide DNA methylation profiling MR Hassler, W Pulverer, R Lakshminarasimhan, E Redl, J Hacker, ... Cell reports 17 (2), 596-608, 2016 | 80 | 2016 |
| When the guardian sleeps: Reactivation of the p53 pathway in cancer O Merkel, N Taylor, N Prutsch, PB Staber, R Moriggl, SD Turner, L Kenner Mutation Research/Reviews in Mutation Research 773, 1-13, 2017 | 75 | 2017 |
| Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis C Gong, JA Krupka, J Gao, NF Grigoropoulos, G Giotopoulos, R Asby, ... Molecular cell 81 (19), 4059-4075. e11, 2021 | 74 | 2021 |
Lukas KennerProf. für Experimentelle PathologieE-mail megerősítve itt: vetmeduni.ac.at